Illinois Medical Marijuana Will Soon Take The Place Of Opioids For Pain Patients

With so much of the nation legalizing cannabis, it was only a matter of time before Illinois medical marijuana would become available to pain patients, especially when considering the epidemic that’s taking place. Illinois pain patients have been dying far too often, and with the opioid epidemic underway, it’s time for the state to fight back.

Former Gov. Bruce Rauner has signed a new law that was put in place Friday, February 1, 2019. With this law, pain patients will be allowed to choose Illinois medical marijuana instead of the traditional and deadlier option, opioids.

The patients qualifying for Illinois medical marijuana will need to get a note from their doctor to verify their condition is legitimate. Once this step is completed, they’ll be allowed to apply for a 90-day medical card through the Opioid Alternative Pilot Program. This program works in conjunction with Illinois’s medical marijuana program. Once the patient’s 90 days are up, they will need to have their doctor new their card.

Melaney Arnold, the spokeswoman for the Illinois Department of Public Health, is quoted as follows, “[Opioid patients] will be registered, either online by establishing an account, or at a dispensary and have immediate access to medical cannabis.”

Illinois medical marijuana applicants will also now be able to qualify for provisional access to this program. With this being the case, the hope is that the backlog of applications should be handled. The sad fact of the matter is that some of the applicants have been waiting for months to receive their Illinois medical marijuana card.

Once these applicants receive their provisional registration letters confirming their applications and fees are in the system processing, these applicants will be allowed to buy Illinois medical marijuana products for the following 90 days. This card can be renewed after the initial 90 days if they still have yet to receive their permanent medical card.

Leave a Reply

Your email address will not be published. Required fields are marked *